COX-2 inhibition as a treatment approach in schizophrenia: Immunological considerations and clinical effects of celecoxib add-on therapy

M�ller, Norbert; Ulmschneider, Markus; Scheppach, Constanze; Schwarz, Markus J.; Ackenheil, Manfred; M�ller, Hans-J�rgen; Gruber, Rudolf; Riedel, Michael
February 2004
European Archives of Psychiatry & Clinical Neuroscience;2004, Vol. 254 Issue 1, p14
Academic Journal
Recent advances in immunological research regarding the differentiation between the type-1 and type-2 immune response are discussed. Increased levels of Interleukin-6 (IL-6) and the activation of the IL-6 system in schizophrenia might be the result of the activation of type-2 monocytes/macrophages, too. On the contrary, several parameters of the specific cellular immune system are blunted, e. g. the decreased type-1 related immune parameters in schizophrenic patients. This study was performed as a double-blind, placebo-controlled, randomized evaluation of risperidone and celecoxib versus risperidone and placebo. Fifty schizophrenic patients were included in the study: 25 patients received risperidone and placebo, and 25 patients received risperidone and celecoxib for 5 weeks after the wash-out period. The treatment effect was calculated by ANCOVA. In parallel, serum levels of sTNF-R1 and sIL- 2R, and the percentages of CD3[sup +]-, CD4[sup +]-, and CD19[sup +] lymphocytes were estimated. As expected, both groups of schizophrenic patients showed significant improvement. However, the celecoxib add-on therapy group showed a significant group effect in the PANSS total score. The cytokines and lymphocytes reflected the type-1/type-2 balancing effects of COX-2 inhibitors. Additional treatment with celecoxib has significant positive effects on the therapeutic action of risperidone with regard to the total schizophrenia psychopathology. Moreover, the fact that treatment with an immunomodulatory drug shows beneficial effects on the symptomatology of schizophrenia indicates that immune dysfunction in schizophrenia is not just an epiphenomenon, but related to the pathomechanism of the disorder.


Related Articles

  • Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension. Lee, Dexter L.; Wilson, Justin L.; Duan, Rong; Hudson, Tamaro; El-Marakby, Ahmed // PPAR Research;2011, Special section p1 

    Peroxisome proliferator-activated receptor-alpha (PPAR-α) activation by fenofibrate reduces blood pressure and sodium retention during DOCA-salt hypertension. PPAR-α activation reduces the expression of inflammatory cytokines, such as interleukin-6 (IL-6). Fenofibrate also induces...

  • Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6. Krause, Daniela; Wagner, Jenny; Wildenauer, Agnes; Matz, Judith; Weidinger, Elif; Riedel, Michael; Obermeier, Michael; Gruber, Rudolf; Schwarz, Markus; Müller, Norbert // European Archives of Psychiatry & Clinical Neuroscience;Aug2012, Vol. 262 Issue 5, p393 

    Several studies have shown an involvement of the immune system, in particular the monocytic system, in the pathophysiology of schizophrenia. Beside others, the monocyte-derived cytokines TNF-α, IL-6 and IL-10 were found to be affected. Since cytokines are secreted by several different cell...

  • Gene of the month: Interleukin 6 (IL-6). Ataie-Kachoie, Parvin; Pourgholami, Mohammad H.; Richardson, Des R.; Morris, David L. // Journal of Clinical Pathology;Nov2014, Vol. 67 Issue 11, p932 

    The Interleukin 6 (IL-6) gene encodes the classic proinflammatory cytokine IL-6. It is also known as interferon-β2 (IFN-β2), B cell stimulatory factor-2 and hybridoma/plasmacytoma growth factor. IL-6 is a multifunctional cytokine with a central role in many physiological inflammatory and...

  • Immunology highlights from the recent literature.  // Nature Immunology;Jan2001, Vol. 2 Issue 1, p21 

    Reports on developments pertaining to immunology, compiled as of January 2001. Helical cytokine identified by searching sequence databases with an interleukin-6 subfamily structure; Lipid raft-independent signaling; Hepatitis C virus.

  • Titanium particles induce the Immediate early stress responsive chemokines IL-B and MCP-1in osteoblasts. FRITZ; STANFORD // International Journal of Oral & Maxillofacial Implants;Nov/Dec2002, Vol. 17 Issue 6, p887 

    The article discusses research being done on human osteoblasts and titanium particles. It references a study by E. A. Fritz et al, published in a 2002 issue of the "Journal of Orthopaedic Research." The study examined whether titanium particles can increase interleukin-6 release and suppress the...

  • In vivo immunomodulatory effects of antipsychotics on inflammatory mediators: A review. Tourjman, Val�rie; Kou�, Marie-�ve; Kouassi, Edouard; Potvin, St�phane // Advances in Bioscience & Biotechnology;Aug2012, Vol. 3 Issue 4, p551 

    Background: Substantial evidence demonstrates the presence of an inflammatory syndrome in schizophrenia, which is manifested by increased peripheral levels of interleukin-6 (IL-6), soluble interleukin-2 receptor (sIL-2R), and interleukin-1 receptor antagonist (IL-1RA). Unfortunately, the...

  • Relationship between Interleukin-6 Plasma Concentration in Patients with Sepsis, Monocyte Phenotype, Monocyte Phagocytic Properties, and Cytokine Production. Spittler, Andreas; Razenberger, Martina; Kupper, Hartmut; Kaul, Martin; Hackl, Werner; Boltz-Nitulescu, George; Fugger, Reinhold; Roth, Erich // Clinical Infectious Diseases;12/1/2000, Vol. 31 Issue 6, p1338 

    Deals with a study which investigated monocyte phenotype, their phagocytic capacity and cytokine production in patients with sepsis with low interleukin-6 plasma concentration. Methods; Results; Discussion.

  • Psychiatric disorders and immune activity. Hornig-Rohan, Mady // Advances: The Journal of Mind-Body Health;Fall94, Vol. 10 Issue 4, p55 

    Presents an abstract of the research study entitled `Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness,' by R. Ganguli et al.

  • Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue Levy, Alegria; Valero, Nereida; Espina, Luz Marina; Añez, Germán; Arias, Julia; Mosquera, Jesús // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jan2010, Vol. 104 Issue 1, p16 

    Summary: This study evaluated the levels of TNFα, IL-6, IL-1β, nitric oxide (NO), CRP, C3 and apoptosis in 36 patients with dengue fever (DF), 34 patients with dengue haemorrhagic fever (DHF) and in virus-infected monocyte cultures. IL-6, TNFα, NO (nitrites) and CRP levels were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics